Tweets: SEPR (Sepracor)

chart
SEPR (Sepracor - Msgs, Twts, Profile)

pharma_sector via Twitter 11:54 AM  09/15/17 reply  |  re-tweet

#Sunovion???s Aptiom (Eslicarbazepine Acetate) Receives FDA Approval For Expanded Indicatio... Read more: https://t.co/WD4BgIP5lB $SEPR (Msgs, Twts)

biotech_sector via Twitter 11:54 AM  09/15/17 reply  |  re-tweet

#Sunovion???s Aptiom (Eslicarbazepine Acetate) Receives FDA Approval For Expanded Indicatio... Read more: https://t.co/HdUkATckIb $SEPR (Msgs, Twts)

pharma_sector via Twitter 08:15 AM  09/14/17 reply  |  re-tweet

#Sunovion to Present Data Across Multiple Psychiatric Conditions at the 2017 Psych Congress. Read more: https://t.co/U8MRCd99vC $SEPR (Msgs, Twts)

biotech_sector via Twitter 08:15 AM  09/14/17 reply  |  re-tweet

#Sunovion to Present Data Across Multiple Psychiatric Conditions at the 2017 Psych Congress. Read more: https://t.co/3kkHrNUgEK $SEPR (Msgs, Twts)

biotech_sector via Twitter 11:44 PM  09/12/17 reply  |  re-tweet

#Sunovion Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Rep... Read more: https://t.co/vEqRmprUqP $SEPR (Msgs, Twts)

biotech_sector via Twitter 05:45 PM  09/08/17 reply  |  re-tweet

#Sunovion seeks FDA approval for dasotraline to treat patients with ADHD. Read more: https://t.co/lUKrqsKb5H $SEPR (Msgs, Twts)

biotech_sector via Twitter 04:57 PM  09/08/17 reply  |  re-tweet

#Sunovion Submits New Drug Application for Dasotraline to the FDA for ADHD. Read more: https://t.co/7lmfzOptCs $SEPR (Msgs, Twts)

biotech_sector via Twitter 04:22 PM  09/08/17 reply  |  re-tweet

#Sunovion submits NDA for dasotraline to US FDA to treat ADHD patients . Read more: https://t.co/Yt165zYApx $SEPR (Msgs, Twts)

biotech_sector via Twitter 01:52 PM  09/08/17 reply  |  re-tweet

#Sunovion files for approval to market new ADHD drug in the USA. Read more: https://t.co/zH8aUPu70O $SEPR (Msgs, Twts)

biotech_sector via Twitter 10:45 AM  09/08/17 reply  |  re-tweet

#Sunovion Submits New Drug Application for Dasotraline to the FDA for the Treatment of Pati... Read more: https://t.co/xsGpt7SvRX $SEPR (Msgs, Twts)

biotech_sector via Twitter 10:24 AM  09/08/17 reply  |  re-tweet

#Sunovion Submits New Drug Application For Dasotraline To The FDA For The Treatment Of Pati... Read more: https://t.co/GaZa4rqjf1 $SEPR (Msgs, Twts)

biotech_sector via Twitter 12:28 PM  07/25/17 reply  |  re-tweet

Canada approves #Sunovion's schizophrenia drug. Read more: https://t.co/Vi5G97kmgc $SEPR (Msgs, Twts)

biotech_sector via Twitter 12:28 PM  07/25/17 reply  |  re-tweet

#Sunovion???s Latuda (Lurasidone HCI) Receives Health Canada Approval To Treat Adolescents ... Read more: https://t.co/GDMOslKQNj $SEPR (Msgs, Twts)

biotech_sector via Twitter 06:04 PM  07/21/17 reply  |  re-tweet

#Sunovions Latuda lurasidone HCI Receives Health Canada Approval to Treat Adolescents with... Read more: https://t.co/yFCUNtVCSU $SEPR (Msgs, Twts)

biotech_sector via Twitter 01:04 PM  07/21/17 reply  |  re-tweet

#Sunovion???s Latuda (Lurasidone HCI) Receives Health Canada Approval To Treat Adolescents ... Read more: https://t.co/RxID74xJs2 $SEPR (Msgs, Twts)

biotech_sector via Twitter 12:22 PM  07/21/17 reply  |  re-tweet

#Sunovion's Latuda® (lurasidone HCI) Receives Health Canada Approval to Treat Adolescents w... Read more: https://t.co/4c2pRsz6xi $SEPR (Msgs, Twts)

biotech_sector via Twitter 04:06 PM  07/18/17 reply  |  re-tweet

#Sunovion Expands Commitment To Building Stronger Communities Through Partnerships With An... Read more: https://t.co/JX9PZ6VdWc $SEPR (Msgs, Twts)

biotech_sector via Twitter 04:06 PM  07/18/17 reply  |  re-tweet

#Sunovion Expands Commitment to Building Stronger Communities through Partnerships with the... Read more: https://t.co/5jZqOvxTKg $SEPR (Msgs, Twts)

biotech_sector via Twitter 11:48 AM  07/18/17 reply  |  re-tweet

#Sunovion Expands Commitment to Building Stronger Communities through Partnerships with the... Read more: https://t.co/lCDY64yRh7 $SEPR (Msgs, Twts)

biotech_sector via Twitter 10:10 PM  07/17/17 reply  |  re-tweet

#Sunovion divesting asthma and allergy products. Read more: https://t.co/tpd5lUd1ml $SEPR (Msgs, Twts)

biotech_sector via Twitter 08:26 PM  07/17/17 reply  |  re-tweet

#Sunovion to sell asthma and allergy products to Covis Pharma. Read more: https://t.co/2AsuZmd0kR $SEPR (Msgs, Twts)

biotech_sector via Twitter 08:26 PM  07/17/17 reply  |  re-tweet

#Sunovion to sell asthma and allergy products to Covis Pharma. Read more: https://t.co/MNPjDw5R9Z $SEPR (Msgs, Twts)

pharma_sector via Twitter 01:03 PM  07/13/17 reply  |  re-tweet

#Sunovion divests asthma, allergy tech to Covis Pharma. Read more: https://t.co/0V5mwdh0Tg $SEPR (Msgs, Twts)

pharma_sector via Twitter 01:03 PM  07/13/17 reply  |  re-tweet

#Sunovion divests asthma, allergy tech to Covis Pharma. Read more: https://t.co/Ufi7DnKo4M $SEPR (Msgs, Twts)

biotech_sector via Twitter 01:03 PM  07/13/17 reply  |  re-tweet

#Sunovion divests asthma, allergy tech to Covis Pharma. Read more: https://t.co/bqMeZ1b1vl $SEPR (Msgs, Twts)

Top Searches Feeds

StockTalk Aggregated Feed (includes All Daily and Weekly Editions) Add to My Yahoo! Add to Google
Top Searches Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Web BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Twitter BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google

Web BuZZ

140 close
You will be redirected to the Twitter's authorization page to approve the BoardCentral to connect to your Twitter account. After your approval, the tweet you have entered will be posted.
Out